DNA Dynamics, Inc. is a company utilizing diverse DNA-driven technologies in the field of human sciences and beyond.

This new industry of DNA-driven technologies will require the expertise and creativity of thousands of scientists from varied disciplines in both the public and private sectors worldwide. The DNA draft sequence already is impacting the search for genes associated with disease. A number of genes have been pinpointed and associated with breast cancer, muscle disease, deafness, and blindness. Additionally, finding the DNA sequences underlying such common diseases as cardiovascular disease, diabetes, arthritis, and cancer is being aided by the human variation maps generated in the HGP in cooperation with the private sector. These gene therapies provide focused targets for the development of effective new therapies. It is DNA Dynamics' mission to develop these advancements for the benefit of all mankind.

One of the greatest impacts of having the sequence may well be in enabling an entirely new approach to biological research. In the past, researchers studied one or a few genes at a time. With whole-genome sequences and new high-throughput technologies, they can approach questions systematically and on a grand scale. They can study all the genes in a genome, for example, or all the transcripts in a particular tissue or organ or tumor, or how tens of thousands of genes and proteins work together in interconnected networks to orchestrate the chemistry of life. As you can see this new industry of DNA driven technologies and their applications will have significant impact on the medical industry and beyond.